Recently, China's first product to perform electrical stimulation and nerve signal extraction in the brainstem region, the “auditory brainstem implant”, was approved by the State Drug Administration for registration as an innovative product. The product was developed by Yuhang Enterprise Zhejiang Norcon Neuroelectronics Technology Co., Ltd. in collaboration with Professor Wu Hao of the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine. It took five years of effort. The developed product can directly bypass damaged nerves and rebuild hearing on the “brain stem” of life, filling the gap in this field in China.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.